期刊文献+

非小细胞肺癌KAI1基因和TIMP-1、MMP-9表达与临床生物学行为的关系研究 被引量:5

Research on the expressions of KAI1 gene, TIMP-1 and MMP-9 and their correlations with clinicopathologic features of non-small cell lung cancer
在线阅读 下载PDF
导出
摘要 目的探讨KAI1基因和基质金属蛋白酶抑制剂1(TIMP-1)、基质金属蛋白酶9(MMP-9)在非小细胞肺癌(NSCLC)中的表达,分析其与临床生物学行为的关系。方法应用免疫组化法检测73例NSCLC、51例相应的癌旁组织和13例非肿瘤性肺组织的KAI1和TIMP-1、MMP-9的表达,采用χ2检验和Pearson法分析三者与临床生物学行为的相关性。结果在73例NSCLC和64例癌旁及非肿瘤组织中,KAI1和TIMP-1的阳性率分别为39.7%、74.0%和90.6%、37.5%,两者比较差异有统计学意义(P<0.05),而MMP-9阳性率为79.4%和67.1%,两者比较差异无统计学意义(P>0.05)。在NSCLC组织中,KAI1检出率在不同TNM分期、淋巴结有无转移、不同肿瘤类型中差异有统计学意义(P<0.05),TIMP-1、MMP-9的检出率在不同TNM分期、淋巴结有无转移中差异有统计学意义(P<0.05),三者检出率与年龄、性别无关;KAI1的表达与TIMP-1、MMP-9呈负相关(r=-0.463 7、-0.344 5,P<0.05)。结论 KAI1和TIMP-1、MMP-9均与肺癌的发展、转移有关,联合检测三者可成为评价NSCLC发生、发展的预后参考指标。 Objective To investigate the expressions of KAI1 gene,tissue inhibitor 1 of metalloproteinase (TIMP-1)and matrix metalloproteinase 9 (MMP-9)in non-small cell lung cancer (NSCLC)and their correlations with clinicopathologic features of NSCLC.Methods The expressions of KAI1 ,TIMP-1 and MMP-9 in 73 specimens of NSCLC tissues,51 specimens of corresponding adjacent tissues and 13 specimens of non-cancerous lung tissue were determined by immunohistochemistry.Their correlations with clinicopathologic features were analyzed by χ2 test and Pearson analysis.Results In 73 specimens of NSCLC tissues and 64 cases of corresponding adjacent and non-cancerous lung tissues,the positive rates of KAI1 and TIMP-1 were 39.7%,74.0% and 90.6%,37.5% with statistical significance (P 〈0.05 ),and the positive rates of MMP-9 were 79.4%,67.1% without statistical significance (P〉0.05 ).The expression of KAI1 was correlated to TNM stage,lymph node metastasis,histologic subtype and differentiation with statistical significance (P〈0.05),and the TIMP-1 and MMP-9 were correlated to TNM stage and lymph node metastasis (P〈0.05),but they were not correlated to age and sex.The expression of KAI1 was negatively correlated with the expressions of TIMP-1 and MMP-9 (r=-0.463 7,-0.344 5,P〈0.05).Conclusions The KAI1 ,TIMP-1 and MMP-9 are related to the development of lung cancer.The combination determination of them will be the important prognosis reference indicator for the occurrence and development of NSCLS.
出处 《检验医学》 CAS 2014年第3期279-282,共4页 Laboratory Medicine
关键词 KAI1 基因 基质金属蛋白酶抑制剂1 基质金属蛋白酶9 肺肿瘤 非小细胞性 KAI1 gene Tissue inhibitor 1 of metalloproteinase Matrix metalloproteinase 9 Lung neoplasm Non-small cell
作者简介 朱波,男,1961年生,主任技师,主要从事肿瘤病因、机制及分子诊断研究. 通讯作者:欧超,联系电话:0771-5333422.
  • 相关文献

参考文献3

二级参考文献29

  • 1Bing-HuiLi PengZhao Shi-ZhengLiu Yue-MingYu MeiHan Jin-KunWen.Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis[J].World Journal of Gastroenterology,2005,11(20):3046-3050. 被引量:21
  • 2蔡铭,谢宗涛,翁鸢,常庆,常建华.韧黏素-C的分解与早期肺癌的术后复发转移[J].中华肿瘤杂志,2007,29(7):518-521. 被引量:1
  • 3Roy R,Yang J,Moses MA.Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.J Clin Oncol,2009,27:5287-5297.
  • 4Davies B,Waxman J,Wasan H,et al.Levels of matrix metalloproteinase in bladder cancer correlate with tumor grade and invasion.Cancer Res,1993,53:5365-5369.
  • 5Muller D,Breathnach R,Engelmann A,et al.Fxpression of collagenaserelated metalloproteinase genes in human lung or head and neck tumors.Int J Cancer,1991,48:550-556.
  • 6Suzuki M,lizasa T,Fujisawa T,et al.Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non.small.Cell lung cancer.Invasion Me tastasis,98-99,18:134-141.
  • 7Sridhar S C,Miranti C K.Tetraspanin KAI1/CD82 suppresses inva- sion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncegene . 2006
  • 8Odintsova E,Sugiura T,Berditchevski F.Attenuation of EGF recep- tor signaling by a metastasis suppressor,the tetraspanin CD82/KAI-1. Current Biology . 2000
  • 9Lo T L,Yusoff P,Fong C W,et al.The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, Sprouty 1 and Sprouty 2 are deregulated in breast cancer. Cancer Research . 2004
  • 10McKie A B,Douglas D A,Olijslagers S,et al.Epigenetic inactivation of the human Sprouty2(hSPRY2)homologue in prostate cancer. Oncegene . 2005

共引文献21

同被引文献44

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部